HFA Premium Access

Natriuretic peptides for detection of heart failure in patients with atrial fibrillation from the community

Congress Presentation

About the speaker

Professor Frans Hendrik Rutten

University Medical Center Utrecht, Utrecht (Netherlands (The))
13 presentations
0 follower

24 more presentations in this session

The value of NT-proBNP in the diagnosis of cardiac disease in patients with alcoholic liver cirrhosis

Speaker: Associate Professor P. Lazarev (Moscow, RU)


Not changes in heart failure therapy but patient characteristics at admission predict unsuccessful guidance of therapy to a target of more than 30% NT-proBNP reduction

Speaker: Miss S. Stienen (Amsterdam, NL)


Sacubitril/valsartan prevents the acute increase of n-terminal brain natriuretic peptide induced by exercise training in subjects with heart failure


The diagnostic and economic implications of using a plasma nt-probnp of 300 or 400ng/litre as the threshold for ruling out the diagnosis of heart failure in a non selected british population

Speaker: Doctor J. Webb (London, GB)


Diagnostic accuracy of plasma ntprobnp in patients over 80 years of age in a non selected british population

Speaker: Miss J. Draper (London, GB)


Access the full session

Poster Session 2 - Biomarkers

Speakers: Professor F. Rutten, Associate Professor P. Lazarev, Miss S. Stienen, Doctor J. Webb, Miss J. Draper

About the event


Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb